599 filings
Page 10 of 30
6-K
e54mt
5 Aug 16
Portage Appoints a New Director
12:00am
6-K
08e4pba qyn4
21 Jul 16
Current report (foreign)
12:00am
6-K
zd6 nlpo7h
7 Jul 16
Fda Clears Biohaven's Ind for BHV-4157 Ans Portage to Hold Investor Conference Call
12:00am
6-K
0e4i8yni97e qcojt
26 May 16
Portage Announces Orphan Drug Designation Request Granted Fto Biohaven for BHV 4157
12:00am
6-K
6y6yqrbx
27 Apr 16
Biohaven Appoints Chief Commercial Officer
12:00am
6-K
v3ihzmcqw1m9tktpbrb
7 Apr 16
Portage Provides Corporate Updates
12:00am
6-K
6c08 gic26t
23 Mar 16
Portage Invests Further In Biohaven
12:00am
6-K
ur7sbpt75p
21 Mar 16
Orphan Drug Designation Received by Biohaven
12:00am
6-K
d60xkp z93g1
14 Mar 16
Announcement of Proposed Private Placement
12:00am
6-K
brk xbgr92
26 Feb 16
Third Quarter 16 Financials and Mda
12:00am
6-K
gc62e2g8x389x
25 Feb 16
Expedited Development Path for BHV 0223 for Biohaven
12:00am
6-K
fvrolx q349l
25 Feb 16
Positive Results from Phase 1 Study with BHV-0223
12:00am
6-K
f1c26o6yw9b3m10
8 Feb 16
Notice of Record and Mailing Date
12:00am
6-K
936myrol 4gj
25 Jan 16
Portage Provides PPL Updates
12:00am
6-K
0lt9i363ci53
1 Dec 15
Interim Financials for the Six Months Ended Sept 30, 2015
12:00am
6-K
8n5j48xzz25cgt
23 Nov 15
Biohaven Phase 1 Trials
12:00am
6-K
frznac
6 Oct 15
Biohaven Completes Multiple Dosing In Phase One Trial
12:00am
6-K
r6seol04dn14m
2 Oct 15
Strategic Alliance with Fox Chase Chemical
12:00am
6-K
dkxj5
21 Sep 15
Biohaven Completes Single Dose Phase
12:00am